Harrison SA - Search Results

1

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. Chalasani N, et al. Among authors: harrison sa. Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29. Hepatology. 2018. PMID: 28714183 Review. No abstract available.

2

Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C.

Harrison SA, Brunt EM, Qazi RA, Oliver DA, Neuschwander-Tetri BA, Di Bisceglie AM, Bacon BR. Harrison SA, et al. Clin Gastroenterol Hepatol. 2005 Jun;3(6):604-9. doi: 10.1016/s1542-3565(05)00246-6. Clin Gastroenterol Hepatol. 2005. PMID: 15952103

3

Diabetic hepatosclerosis: diabetic microangiopathy of the liver.

Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM. Harrison SA, et al. Arch Pathol Lab Med. 2006 Jan;130(1):27-32. doi: 10.5858/2006-130-27-DHDMOT. Arch Pathol Lab Med. 2006. PMID: 16390234 Free article.

4

Impact of obesity on treatment of chronic hepatitis C.

Charlton MR, Pockros PJ, Harrison SA. Charlton MR, et al. Among authors: harrison sa. Hepatology. 2006 Jun;43(6):1177-86. doi: 10.1002/hep.21239. Hepatology. 2006. PMID: 16729327 Review.

5

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Harrison SA, et al. Hepatology. 2009 Jan;49(1):80-6. doi: 10.1002/hep.22575. Hepatology. 2009. PMID: 19053049 Clinical Trial.

6

Vascular disorders of the liver.

DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. DeLeve LD, et al. Hepatology. 2009 May;49(5):1729-64. doi: 10.1002/hep.22772. Hepatology. 2009. PMID: 19399912 Free PMC article.

7

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.

Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Gastaldelli A, et al. Among authors: harrison sa. Hepatology. 2009 Oct;50(4):1087-93. doi: 10.1002/hep.23116. Hepatology. 2009. PMID: 19670459 Clinical Trial.

8

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.

Starley BQ, Calcagno CJ, Harrison SA. Starley BQ, et al. Among authors: harrison sa. Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594. Hepatology. 2010. PMID: 20432259 Review.

9

Manifestations of chronic hepatitis C virus infection beyond the liver.

Jacobson IM, Cacoub P, Dal Maso L, Harrison SA, Younossi ZM. Jacobson IM, et al. Among authors: harrison sa. Clin Gastroenterol Hepatol. 2010 Dec;8(12):1017-29. doi: 10.1016/j.cgh.2010.08.026. Epub 2010 Sep 24. Clin Gastroenterol Hepatol. 2010. PMID: 20870037 Review.

10

Nonalcoholic fatty liver disease: is it all in the genes?

Torres DM, Harrison SA. Torres DM, et al. Among authors: harrison sa. Hepatology. 2010 Nov;52(5):1851-4. doi: 10.1002/hep.24020. Hepatology. 2010. PMID: 21038421 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

375 results

Search Page